Bastiano Sanna is EVP, Cell & Genetic Therapies of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 32,038 shares of VRTX, which is worth approximately $15 Million. The most recent transaction as insider was on May 08, 2023, when has been sold 2,850 shares (Common Stock) at a price of $350.0 per share, resulting in proceeds of $997,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 32K
0% 3M change
0% 12M change
Total Value Held $15 Million

Bastiano Sanna Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 08 2023
SELL
Open market or private sale
$997,500 $350.0 p/Share
2,850 Reduced 8.17%
32,038 Common Stock
May 05 2023
SELL
Open market or private sale
$147,712 $350.03 p/Share
422 Reduced 1.2%
34,888 Common Stock
May 03 2023
SELL
Open market or private sale
$976,186 $351.02 p/Share
2,781 Reduced 7.3%
35,310 Common Stock
May 02 2023
SELL
Open market or private sale
$570,522 $351.74 p/Share
1,622 Reduced 4.08%
38,091 Common Stock
Apr 12 2023
SELL
Open market or private sale
$2,470,852 $326.53 p/Share
7,567 Reduced 16.0%
39,713 Common Stock
Apr 04 2023
SELL
Open market or private sale
$165,259 $316.59 p/Share
522 Reduced 1.09%
47,280 Common Stock
Mar 31 2023
SELL
Payment of exercise price or tax liability
$459,942 $313.74 p/Share
1,466 Reduced 2.98%
47,802 Common Stock
Mar 16 2023
SELL
Open market or private sale
$826,024 $300.81 p/Share
2,746 Reduced 5.28%
49,268 Common Stock
Feb 24 2023
SELL
Payment of exercise price or tax liability
$1,147,806 $289.12 p/Share
3,970 Reduced 7.09%
52,014 Common Stock
Feb 17 2023
SELL
Payment of exercise price or tax liability
$1,098,187 $292.85 p/Share
3,750 Reduced 6.28%
55,984 Common Stock
Feb 14 2023
SELL
Open market or private sale
$655,826 $300.7 p/Share
2,181 Reduced 3.52%
59,734 Common Stock
Feb 13 2023
SELL
Payment of exercise price or tax liability
$1,294,448 $298.26 p/Share
4,340 Reduced 6.54%
62,028 Common Stock
Feb 13 2023
SELL
Open market or private sale
$33,944 $300.39 p/Share
113 Reduced 0.18%
61,915 Common Stock
Feb 10 2023
SELL
Payment of exercise price or tax liability
$265,485 $294.33 p/Share
902 Reduced 1.34%
66,368 Common Stock
Feb 01 2023
BUY
Grant, award, or other acquisition
-
29,272 Added 30.32%
67,270 Common Stock
Jan 31 2023
SELL
Open market or private sale
$34,450 $325.0 p/Share
106 Reduced 0.28%
37,998 Common Stock
Nov 02 2022
SELL
Open market or private sale
$100,339 $313.56 p/Share
320 Reduced 0.83%
38,104 Common Stock
Nov 01 2022
SELL
Payment of exercise price or tax liability
$240,261 $312.84 p/Share
768 Reduced 1.96%
38,424 Common Stock
Oct 18 2022
SELL
Open market or private sale
$538,966 $300.93 p/Share
1,791 Reduced 4.37%
39,192 Common Stock
Aug 01 2022
SELL
Payment of exercise price or tax liability
$211,891 $276.62 p/Share
766 Reduced 1.83%
40,983 Common Stock
May 16 2022
SELL
Open market or private sale
$11,365 $252.56 p/Share
45 Reduced 0.11%
41,749 Common Stock
May 04 2022
SELL
Open market or private sale
$9,903 $275.09 p/Share
36 Reduced 0.09%
41,660 Common Stock
May 02 2022
SELL
Open market or private sale
$83,091 $259.66 p/Share
320 Reduced 0.76%
41,696 Common Stock
Apr 29 2022
SELL
Payment of exercise price or tax liability
$211,546 $276.17 p/Share
766 Reduced 1.79%
42,016 Common Stock
Apr 07 2022
SELL
Open market or private sale
$155,044 $276.37 p/Share
561 Reduced 1.29%
42,782 Common Stock

Also insider at

ACET
Adicet Bio, Inc. Healthcare
BS

Bastiano Sanna

EVP, Cell & Genetic Therapies
Boston, MA

Track Institutional and Insider Activities on VRTX

Follow VERTEX PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX